Probiotics, immunostimulants, plant products and oral vaccines, and their role as feed supplements in the control of bacterial fish diseases.

There is a rapidly increasing literature pointing to the success of probiotics, immunostimulants, plant products and oral vaccines in immunomodulation, namely stimulation of the innate, cellular and/or humoral immune response, and the control of bacterial fish diseases. Probiotics are regarded as live micro-organisms administered orally and leading to health benefits. However, in contrast with the use in terrestrial animals, a diverse range of micro-organisms have been evaluated in aquaculture with the mode of action often reflecting immunomodulation. Moreover, the need for living cells has been questioned. Also, key subcellular components, including lipopolysaccharides, have been attributed to the beneficial effect in fish. Here, there is a link with immunostimulants, which may also be administered orally. Furthermore, numerous plant products have been reported to have health benefits, namely protection against disease for which stimulation of some immune parameters has been reported. Oral vaccines confer protection against some diseases, although the mode of action is usually linked to humoral rather than the innate and cellular immune responses. This review explores the relationship between probiotics, immunostimulants, plant products and oral vaccines.

Development and use of real-time PCR to detect and quantify Mycoplasma haemocanis and "Candidatus Mycoplasma haematoparvum" in dogs.

Two canine haemoplasma species have been recognised to date; Mycoplasma haemocanis (Mhc), which has been associated with anaemia in splenectomised or immunocompromised dogs, and "Candidatus Mycoplasma haematoparvum" (CMhp), recently described in an anaemic splenectomised dog undergoing chemotherapy. The study aim was to develop quantitative real-time PCR assays (qPCRs) incorporating an endogenous internal control to detect Mhc and CMhp and to apply these assays to DNA samples extracted from canine blood collected in Northern Tanzania (n=100) and from dogs presented to a Trinidadian veterinary hospital (n=185). QPCRs specific for Mhc and CMhp were designed using 16S rRNA gene sequence data, and each was duplexed with an assay specific for canine glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The assays detected < or =10 copies of a sequence-specific haemoplasma plasmid per reaction and neither assay showed cross-reactivity with 10(6) copies of the sequence-specific plasmid from the non-target canine haemoplasma species. Nineteen of the 100 Tanzanian samples (19%) were positive for Mhc alone and one (1%) was dually infected. One Trinidadian sample was negative for canine GAPDH DNA and was excluded from the study. Of the 184 remaining Trinidadian samples, nine (4.9%) were positive for Mhc alone, five (2.7%) for CMhp alone, and two (1.1%) dually infected. This is the first report of canine haemoplasma qPCR assays that use an internal control to confirm the presence of amplifiable sample DNA, and their application to prevalence studies. Mhc was the most commonly detected canine haemoplasma species.

Prevalence of bacterial pathogens and their anti-microbial resistance in Tilapia and their pond water in Trinidad.

In Trinidad, Tilapia (Oreonchromis spp.) is one of the most important fresh water food fish and the number of farms has been increasing annually. A study was conducted in the local tilapia industry to determine the microbial quality of pond water, prevalence of bacterial pathogens and their anti-microbial resistance using the disk diffusion method. Seventy-five apparently healthy fish and 15 pond water samples from three of the four commercial tilapia fish farms in the country were processed. The 202 bacterial isolates recovered from fish slurry and 88 from water, belonged to 13 and 16 genera respectively. The predominant bacteria from fish slurry were Pseudomonas spp. (60.0%), Aeromonas spp. (44.0%), Plesiomonas (41.3%) and Chromobacterium (36.0%) (P < 0.05; chi(2)) compared with isolates from pond water where Bacillus spp. (80.0%), Staphylococcus spp., Alcaligenes spp. and Aeromonas spp. (60.0%) were most prevalent (P < 0.05; chi(2)). Using eight anti-microbial agents, to test bacteria from five genera (Aeromonas, Chromobacterium, Enterobacter, Plesiomonas and Pseudomonas), 168 (97.1%) of 173 bacterial isolates from fish slurry exhibited resistance to one or more anti-microbial agents compared with 47 (90.4%) of 52 from water (P > 0.05; chi(2)). Resistance was high to ampicillin, 90.2% (158 of 173), erythromycin, 66.5% (115 of 173) and oxytetracycline, 52.6%, (91 of 173) but relatively low to chloramphenicol, 9.8% (17 of 173) and sulphamethoxazole/trimethoprim, 6.4% (11 of 173) (P < 0.05; chi(2)). For pond water isolates, the frequency of resistance across bacterial genera ranged from 75% (nine of 12) for Chromobacter spp. to 100% found amongst Enterobacter spp. (six of six), Plesiomonas spp. (nine of nine) and Pseudomonas spp. (eight of eight) (P < 0.05; chi(2)). Resistance was generally high to ampicillin, 78.8% (41 of 52), erythromycin, 51.9% (27 of 52) and oxytetracycline, 34.5% (18 of 52) but low to sulphamethoxazole/trimethoprim, 7.7% (four of 52) and norfloxacin, 3.8% (two of 52) (P < 0.05; chi(2)). It was concluded that the rather high prevalence of bacterial pathogens in tilapia along with their high prevalence of resistance to anti-microbial agents might pose therapeutic problems as well as health risk to consumers. The microbial presence and their anti-microbial resistance in the tilapia industry are being reported for the first time in the country.

Prevalence of bacterial pathogens and their anti-microbial resistance in Tilapia and their pond water in Trinidad.

In Trinidad, Tilapia (Oreonchromis spp.) is one of the most important fresh water food fish and the number of farms has been increasing annually. A study was conducted in the local tilapia industry to determine the microbial quality of pond water, prevalence of bacterial pathogens and their anti-microbial resistance using the disk diffusion method. Seventy-five apparently healthy fish and 15 pond water samples from three of the four commercial tilapia fish farms in the country were processed. The 202 bacterial isolates recovered from fish slurry and 88 from water, belonged to 13 and 16 genera respectively. The predominant bacteria from fish slurry were Pseudomonas spp. (60.0 per cent), Aeromonas spp. (44.0 per cent), Plesiomonas (41.3 per cent) and Chromobacterium (36.0 per cent) (P < 0.05; chi(2)) compared with isolates from pond water where Bacillus spp. (80.0 per cent), Staphylococcus spp., Alcaligenes spp. and Aeromonas spp. (60.0 per cent) were most prevalent (P < 0.05; chi(2)). Using eight anti-microbial agents, to test bacteria from five genera (Aeromonas, Chromobacterium, Enterobacter, Plesiomonas and Pseudomonas), 168 (97.1 per cent) of 173 bacterial isolates from fish slurry exhibited resistance to one or more anti-microbial agents compared with 47 (90.4 per cent) of 52 from water (P > 0.05; chi(2)). Resistance was high to ampicillin, 90.2 per cent (158 of 173), erythromycin, 66.5 per cent (115 of 173) and oxytetracycline, 52.6 per cent, (91 of 173) but relatively low to chloramphenicol, 9.8 per cent (17 of 173) and sulphamethoxazole/trimethoprim, 6.4 per cent (11 of 173) (P < 0.05; chi(2)). For pond water isolates, the frequency of resistance across bacterial genera ranged from 75 per cent (nine of 12) for Chromobacter spp. to 100 per cent found amongst Enterobacter spp. (six of six), Plesiomonas spp. (nine of nine) and Pseudomonas spp. (eight of eight) (P < 0.05; chi(2))...

Bacillus subtilis AB1 controls Aeromonas infection in rainbow trout (Oncorhynchus mykiss, Walbaum).

AIM: To develop a probiotic with effectiveness against Aeromonas sp., which was pathogenic to rainbow trout. METHODS AND RESULTS: When Bacillus subtilis AB1, which was obtained from fish intestine, was administered for 14 days to rainbow trout in feed at a concentration of 10(7) cells per gram either as viable, formalized or sonicated cells or as cell-free supernatant, the fish survived challenge with the pathogen. AB1 stimulated immune parameters, specifically stimulating respiratory burst, serum and gut lysozyme, peroxidase, phagocytic killing, total and alpha1-antiprotease and lymphocyte populations. CONCLUSIONS: Bacillus subtilis AB1 was effective as a probiotic at controlling infections by a fish-pathogenic Aeromonas sp. in rainbow trout. SIGNIFICANCE AND IMPACT OF THE STUDY: Disease control in fish is possible by means of the oral application of live and inactivated cells and their subcellular components with the mode of action reflecting stimulation of the innate immune response.

The development of probiotics for the control of multiple bacterial diseases of rainbow trout, Oncorhynchus mykiss (Walbaum).

JB-1 and GC2, which were equated with Bacillus sp. and Aeromonas sobria respectively, were recovered from the digestive tract of rainbow trout, Oncorhynchus mykiss and ghost carp, Cyprinus sp. respectively, and demonstrated effectiveness as probiotics for the control of infections caused by Aeromonas salmonicida, Lactococcus garvieae, Streptococcus iniae, Vibrio anguillarum, Vibrio ordalii and Yersinia ruckeri. When administered to rainbow trout (average weight = 12 g) for 14 days in feed dosed at 2 x 10(8) cells g(-1) of feed, JB-1 led to a reduction in mortalities to 0-13% after challenge with a range of bacterial pathogens compared to 80-100% mortalities of the controls. Similarly, use of GC2 reduced mortalities to 0-16% following the challenge compared to 80-100% mortalities of the controls. The mode of action reflected nutrition, production of inhibitory substances and stimulation of the innate immune responses. Specifically, JB-1 and especially GC2 were positive for siderophore and chitinase production, and increased lysozyme, phagocytic and respiratory burst activity.

Bacillus subtilis AB1 controls Aeromonas infection in rainbow trout (Oncorhynchus mykiss, Walbaum).

AIM: To develop a probiotic with effectiveness against Aeromonas sp., which was pathogenic to rainbow trout. METHODS AND RESULTS: When Bacillus subtilis AB1, which was obtained from fish intestine, was administered for 14 days to rainbow trout in feed at a concentration of 10(7) cells per gram either as viable, formalized or sonicated cells or as cell-free supernatant, the fish survived challenge with the pathogen. AB1 stimulated immune parameters, specifically stimulating respiratory burst, serum and gut lysozyme, peroxidase, phagocytic killing, total and alpha1-antiprotease and lymphocyte populations. CONCLUSIONS: Bacillus subtilis AB1 was effective as a probiotic at controlling infections by a fish-pathogenic Aeromonas sp. in rainbow trout. SIGNIFICANCE AND IMPACT OF THE STUDY: Disease control in fish is possible by means of the oral application of live and inactivated cells and their subcellular components with the mode of action reflecting stimulation of the innate immune response.